Medication use in the treatment of migraine during pregnancy and lactation

Current Pain and Headache Reports

Volumn 13, Issue 5, 2009, Pages 392-398

  Lucas, Sylvia ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARBITURIC ACID DERIVATIVE; BELIDRAL; BENDECTIN; BENZODIAZEPINE; CARBAMAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CODEINE; DIHYDROERGOTAMINE; DOXYLAMINE; ELETRIPTAN; EMETROL; ERGOTAMINE; HYDROCODONE; ISOTRETINOIN; LAMOTRIGINE; LORAZEPAM; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; ONDANSETRON; OPIATE; OXAZEPAM; PARACETAMOL; PHENYTOIN; PROCHLORPERAZINE; PYRIDOXINE; SUMATRIPTAN; THALIDOMIDE; TRIPTAN DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID; VERAPAMIL; WARFARIN;

CONSTIPATION; DIZZINESS; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG HALF LIFE; DRUG LIVER LEVEL; DRUG METABOLISM; DRUG MONITORING; DRUG PROTEIN BINDING; DRUG RESPONSE; DRUG SAFETY; DRUG TRANSPORT; DRUG USE; DUCTUS ARTERIOSUS OBLITERATION; EDEMA; FETUS HYPOXIA; FETUS RISK; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HUMAN; INTRAUTERINE GROWTH RETARDATION; LACTATION; LIVER TOXICITY; MATERNAL CARE; MECONIUM ILEUS; MIGRAINE; NAUSEA; NAUSEA AND VOMITING; NONHUMAN; PLACENTA PERFUSION; PREGNANCY; PRENATAL DRUG EXPOSURE; RESPIRATION DEPRESSION; RESPIRATORY DISTRESS; REVIEW; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; SPONTANEOUS ABORTION; TERATOGENESIS; TERATOGENICITY; TREATMENT PLANNING; UTERUS BLOOD FLOW; WITHDRAWAL SYNDROME;

ANALGESICS; FEMALE; HUMANS; LACTATION; MIGRAINE DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; TREATMENT OUTCOME; TRYPTAMINES;

EID: 70349638301     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-009-0064-3     Document Type: Review

References (38)

1. Lipton RB, Bigal ME: The epidemiology of migraine. Am J Med 2005, 118(Suppl 1):3S-10S.
2. Marcus DA: Managing headache during pregnancy and lactation. Exp Rev Neurother 2008, 8:385-395.
3. Sances G, Granella F, Nappi R, et al.: Course of migraine during pregnancy and postpartum: A prospective study. Cephalalgia 2003, 23:197-205.
4. Melhado EM, Maciel JA, Guerreiro CM: Headache during gestation: evaluation of 1101 women. Can J Neurol Sci 2007, 34:187-192.
5. Pregnancy categories for prescription drugs. FDA Drug Bulletin 1982, 12:24-25.
6. Boothby LA, Doering PL: FDA labeling systems for drugs in pregnancy. Ann Pharmacother 2001, 35:1485-1489.
7. Koren G, Pastuszak A, Ho S: Drugs in pregnancy. N Engl J Med 1998, 338:1128-1137.
8. Anderson G. Using pharmacokinetics to predict effects of pregnancy and maternal-infant transfer of drug during lactation. Exp Opin Drg Metab Toxicol 2006, 2:947-960.
9. Soldin OP, Dahlin J, O'Mara DM: Triptans in pregnancy. Ther Drug Monit 2008, 30:5-9.
10. Evans EW, Lorbe KC: Use of 5-HT agonists in pregnancy. Ann Pharmacother 2008, 42:543-549.
11. Loder E: Safety of sumatriptanAin pregnancy: a review of the literature so far. CNS Drugs 2003, 17:1-7.
12. O'Quinn S, Ephross SA, Williams V, et al.: Pregnancy and perinatal outcomes in migraineurs using sumatriptan: A prospective study. Arch Gynecol Obstet 1999, 263:7-12.
13. Shuhaiber S, Pastuszak A, Schick B, et al.: Pregnancy outcome following first trimester exposure to sumatriptan. Neurology 1998, 51:581-583.
14. Schenker S, Yang Y, Perez A, et al.: Sumatriptan (Imitrex) transport by the human placenta. Proc Soc Exp Biol Med 1995, 210:213-220.
15. Guputa S, Hanff LM, Visser W, et al.: Functional reactivity of 5-HT receptors in human umbilical cord and maternal subcutaneous fat arteries after normotensive or pre-eclamptic pregnancy. J Hypertens 2006, 24:1345-1353.
16. GlaxoSmithKline: Sumatriptan and naratriptan pregnancy registry interim report (January 1996 through October 31, 2008). Available at http://pregnancyregistry.gsk.com/documents/ sum-nar_interim_report_2009.pdf.
17. Li DK, Liu L, Odouli R: Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: Population based cohort study. Br Med J 2003, 327:368.
18. Silberstein SD for the US Headache Consortium: American Academy of Neurology practice parameter: Evidence-based guidelines for migraine headache (an evidence based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology 2000, 538-547.
19. Einarson A, Maltepe C, Narioz Y, et al.: The safety of ondansetron for nausea and vomiting of pregnancy: A prospective comparative study. BJOG 2004, 111:940-943.
20. Physicians' Desk Reference: Ondansetron. New York, NY: Thomson Reuters; 2009.
21. Karlsson C, Bodelsson G, Bodelsson M, et al.: Characterization of 5-hydroxytrypamine receptors mediating circular smooth muscle contraction in the human umbilical artery. Gynecol Obstet Invest 1999, 47:102-107.
22. Bsat F, Hoiffman DE, Seubert DE: Comparison of three outpatient regimens in the management of nausea and vomiting in pregnancy. J Perinatol 2003, 23:531-535.
23. Gur C, Diav-Citrin O, Shectman S, et al.: Pregnancy outcome after first trimester exposure to corticosteroids: A prospective controlled study. Reprod Toxicol 2004, 18:93-101.
24. Pfaffenrath V, ReWm M: Migraine in pregnancy: what are the safest treatment options? Drug Saf 1998, 19:383-388.
25. Marcus DA: Pregnancy and chronic headache. Expert Opin Pharmacother 2002, 3:389-393.
26. Wall VR: Breastfeeding and migraine headaches. J Hum Lact 1992, 8:209-212.
27. Begg, EJ, Duffull SB, Hackett LP, et al.: Studying drugs in human milk: time to unify the approach. J Hum Lact 2002, 18:323-332.
28. Larsen LA, Ito S, Koren G: Prediction of milk/plasma concentration ratio of drugs. Ann Pharmacother 2003, 37:1299-1300.
29. Atkinson HC, Begg EJ: Prediction of drug distribution into human milk from physicochemical characteristics. Clin Pharmacokinet 1990, 18:151-167.
30. Riant P, Urien S, Albengres E, et al.: High plasma protein binding as a parameter in the selection of betablockers for lactating women. Biochem Pharmacol 1986, 35:4579-4581.
31. Sumatriptan [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2007.
32. Eletriptan [package insert]. New York, NY: Pfizer; 2007.
33. Wojnar-Harton RE, Hackett LP, Yapp P, et al.: Distribution and excretion of sumatriptan in human milk. Br J Clin Pharmacol 1996, 41:217-221.
34. American Academy of Pediatrics Committee on Drugs: Transfer of drugs and other chemicals into human milk. Pediatrics 2001, 108:776-789.
35. American Academy of Pediatrics: Policy statements. Available at http://aappolicy.aappublications.org/cgi/reprint/pediatrics.
36. Hale TW: Medications and Mothers' Milk. Amarillo, TX: Hale Publishing; 2008.
37. Weibert RI, Townsend RJ, Kaiser DG, et al.: Lack of ibuprofen secretion into human milk. Clin Pharm 1982, 1:457-458.
38. Townsend RJ, Benedetti TJ, Erickson SH, et al.: Excretion of ibuprofen into breast milk. Am J Obstet Gynecol 1984, 149:184-186.